This report contains market size and forecasts of Preventable Vaccines in global, including the following market information:
Global Preventable Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Preventable Vaccines Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Preventable Vaccines companies in 2021 (%)
The global Preventable Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Adult Preventable Vaccines Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Preventable Vaccines include GlaxoSmithKline, Merck, Novartis, Pfizer, Sanofi, Takeda Pharmaceutical, Abbott, Roche and AstraZeneca, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Preventable Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Preventable Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Preventable Vaccines Market Segment Percentages, by Type, 2021 (%)
- Adult Preventable Vaccines
- Pediatric Preventable Vaccines
Global Preventable Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Preventable Vaccines Market Segment Percentages, by Application, 2021 (%)
- Bacterial Diseases
- Virus Diseases
Global Preventable Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Preventable Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Preventable Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Preventable Vaccines revenues share in global market, 2021 (%)
- Key companies Preventable Vaccines sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Preventable Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- GlaxoSmithKline
- Merck
- Novartis
- Pfizer
- Sanofi
- Takeda Pharmaceutical
- Abbott
- Roche
- AstraZeneca
- Mitsubishi Tanabe Pharma
- Lupin
- Serum Institute of India
- LG Life Sciences
- S K Chemicals
- Shenzhen Kangtai Biological Products
- Sinovac Biotech
- Janssen Pharmaceuticals
- Crucell
- Bavarian Nordic
- Baxter
- Bharat Biotech
- Dynavax
- Bausch Health
- Protein Sciences
- Panacea Biotec
